Stryker (SYK) Operating Income Growth (3y) (2012 - 2026)
Stryker (SYK) Operating Income Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | 7.13% |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | -2.70% |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 75.54% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 34.83% |
| 10 | Steris | 21.55 Bn | 21.11 Bn | 697.10 Mn | -24.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.39% |
| Dec 31, 2025 | 30.38% |
| Sep 30, 2025 | 11.99% |
| Jun 30, 2025 | 12.97% |
| Mar 31, 2025 | 23.26% |
| Dec 31, 2024 | -10.81% |
| Sep 30, 2024 | 23.64% |
| Jun 30, 2024 | 12.81% |
| Mar 31, 2024 | 28.42% |
| Dec 31, 2023 | 18.84% |
| Sep 30, 2023 | 2.72% |
| Jun 30, 2023 | 269.02% |
| Mar 31, 2023 | 5.00% |
| Dec 31, 2022 | -4.82% |
| Sep 30, 2022 | 8.76% |
| Jun 30, 2022 | 7.99% |
| Mar 31, 2022 | -5.40% |
| Dec 31, 2021 | 5.47% |
| Sep 30, 2021 | -0.12% |
| Jun 30, 2021 | 2.89% |